BRPI0908361A2 - Seringas previamente cheias contendo composição e métodos de preparação das mesmas e de estabilização de agente de ligação específico em composição. - Google Patents

Seringas previamente cheias contendo composição e métodos de preparação das mesmas e de estabilização de agente de ligação específico em composição.

Info

Publication number
BRPI0908361A2
BRPI0908361A2 BRPI0908361A BRPI0908361A2 BR PI0908361 A2 BRPI0908361 A2 BR PI0908361A2 BR PI0908361 A BRPI0908361 A BR PI0908361A BR PI0908361 A2 BRPI0908361 A2 BR PI0908361A2
Authority
BR
Brazil
Prior art keywords
composition
preparing
methods
binding agent
specific binding
Prior art date
Application number
Other languages
English (en)
Inventor
Roberta Bonk
Mingda Eu
Amy Huinker
Monica Pallitto
Margaret Ricci
Nicole Stackhouse
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of BRPI0908361A2 publication Critical patent/BRPI0908361A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
BRPI0908361 2008-02-07 2009-02-05 Seringas previamente cheias contendo composição e métodos de preparação das mesmas e de estabilização de agente de ligação específico em composição. BRPI0908361A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6506508P 2008-02-07 2008-02-07
PCT/US2009/000759 WO2009099641A2 (en) 2008-02-07 2009-02-05 Stabilized protein compositions

Publications (1)

Publication Number Publication Date
BRPI0908361A2 true BRPI0908361A2 (pt) 2015-04-07

Family

ID=40532483

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0908361 BRPI0908361A2 (pt) 2008-02-07 2009-02-05 Seringas previamente cheias contendo composição e métodos de preparação das mesmas e de estabilização de agente de ligação específico em composição.

Country Status (14)

Country Link
US (1) US20110060290A1 (pt)
EP (1) EP2249801A2 (pt)
JP (2) JP2011519347A (pt)
KR (1) KR20100138908A (pt)
CN (2) CN102202643A (pt)
AU (1) AU2009210741A1 (pt)
BR (1) BRPI0908361A2 (pt)
CA (1) CA2714006A1 (pt)
EA (1) EA201001223A1 (pt)
IL (1) IL207340A0 (pt)
MX (1) MX2010008696A (pt)
SG (1) SG10201402265YA (pt)
WO (1) WO2009099641A2 (pt)
ZA (2) ZA201005779B (pt)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG162788A1 (en) 2005-06-14 2010-07-29 Amgen Inc Self-buffering protein formulations
US9265834B2 (en) 2009-03-05 2016-02-23 Ablynx N.V. Stable formulations of polypeptides and uses thereof
US10005830B2 (en) 2009-03-05 2018-06-26 Ablynx N.V. Antigen binding dimer-complexes, methods of making/avoiding and uses thereof
WO2011026945A1 (en) 2009-09-03 2011-03-10 Ablynx N.V. Stable formulations of polypeptides and uses thereof
TWI907924B (zh) * 2011-05-02 2025-12-11 日商武田藥品工業股份有限公司 抗-α4β7抗體之調配物
DK3858405T3 (da) 2012-06-01 2023-07-03 Novartis Ag Sprøjte
DE202013000688U1 (de) 2012-07-03 2013-03-05 Novartis Ag Glas-Spritze
JP6271536B2 (ja) 2012-07-09 2018-01-31 コヒラス・バイオサイエンシズ・インコーポレイテッド 肉眼不可視粒子の著しい低減を示すエタネルセプト製剤
UA117466C2 (uk) 2012-12-13 2018-08-10 Мерк Шарп Енд Доме Корп. СТАБІЛЬНИЙ СКЛАД У ВИГЛЯДІ РОЗЧИНУ АНТИТІЛА ДО IL-23p19
US9744303B2 (en) 2013-07-10 2017-08-29 Merit Medical Systems, Inc. Pre-loaded syringes and methods related thereto
EP3143044A1 (en) * 2014-05-12 2017-03-22 Formycon AG Pre-filled plastic syringe containing a vegf antagonist
WO2016040766A1 (en) * 2014-09-12 2016-03-17 Anthrogenesis Corporation Methods for quantifying particulates in cell culture
AU2015326037A1 (en) * 2014-10-02 2017-04-13 Terumo Kabushiki Kaisha Medical container for accommodating protein solution preparation therein
WO2016066821A1 (en) 2014-10-30 2016-05-06 F. Hoffmann-La Roche Ag Syringe and method of preparing a syringe
CA2968915A1 (en) * 2014-12-03 2016-06-09 Csl Behring Ag Pharmaceutical product with increased stability comprising immunoglobulins
US11229702B1 (en) 2015-10-28 2022-01-25 Coherus Biosciences, Inc. High concentration formulations of adalimumab
US10925927B2 (en) 2015-11-18 2021-02-23 Formycon Ag Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist
US20180326126A1 (en) * 2015-11-18 2018-11-15 Formycon Ag Pre-filled plastic syringe containing a vegf antagonist
EP3377040B8 (en) 2015-11-18 2024-06-05 SiO2 Medical Products, Inc. Pharmaceutical package for ophthalmic formulations
US11472878B2 (en) * 2016-04-15 2022-10-18 The Board Of Trustees Of The Leland Stanford Junior University Methods for determining and achieving therapeutically effective doses of anti-CD47 agents in treatment of cancer
US11071782B2 (en) * 2016-04-20 2021-07-27 Coherus Biosciences, Inc. Method of filling a container with no headspace
AU2017256308A1 (en) * 2016-04-25 2018-12-06 Terumo Kabushiki Kaisha Syringe barrel for pre-filled syringe, syringe system, and pre-filled syringe
WO2018049184A1 (en) 2016-09-09 2018-03-15 Cutispharma, Inc. Suspensions and diluents for metronidazole and baclofen
MX2019004580A (es) 2016-10-21 2019-08-12 Amgen Inc Formulaciones farmaceuticas y metodos para prepararlas.
EP3370040B1 (de) 2017-03-02 2021-04-21 Fresenius Kabi Austria GmbH Verfahren zur bestimmung eines gasvolumens einer fertigspritze und verwendung des verfahrens zur eichung einer anlage zum abfüllen einer fertigspritze
JOP20190255A1 (ar) * 2017-04-28 2019-10-27 Amgen Inc صيغ أجسام مضادة لـ rankl بشري، وطرق لاستخدامها
EP3618871A4 (en) 2017-05-02 2021-01-06 Merck Sharp & Dohme Corp. FORMULATIONS OF ANTI-LAG3 ANTIBODIES AND CO-FORMULATIONS OF ANTI-LAG3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES
JOP20190260A1 (ar) 2017-05-02 2019-10-31 Merck Sharp & Dohme صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها
WO2018217995A1 (en) 2017-05-24 2018-11-29 Formycon Ag Sterilizable pre-filled pharmaceutical packages comprising a liquid formulation of a vegf-antagonist
CA3063995A1 (en) 2017-05-24 2018-11-29 Sio2 Medical Products, Inc. Sterilizable pharmaceutical package for ophthalmic formulations
JP6635454B1 (ja) * 2019-04-16 2020-01-22 株式会社Ｋｏｒｔｕｃ シリコーンオイル（を含有するオイル組成物）により優れた過酸化水素保存性を示す過酸化水素溶液プレフィルドガラス製シリンジ
EP3775315A1 (en) 2018-03-27 2021-02-17 SiO2 Medical Products, Inc. Vessels, containers, and surfaces coated with water barrier coatings
JP7467438B2 (ja) 2018-10-18 2024-04-15 メルク・シャープ・アンド・ドーム・エルエルシー 抗ｒｓｖ抗体の製剤及びその使用方法
JP2019048091A (ja) * 2018-10-23 2019-03-28 ニプロ株式会社 デクスメデトミジン注射液を充填したプレフィルドシリンジ
WO2020092233A1 (en) 2018-10-31 2020-05-07 Merck Sharp & Dohme Corp. Anti-human pd-1 antibody crystals and methods of use thereof
MX2021005394A (es) 2018-11-07 2021-07-06 Merck Sharp & Dohme Llc Co-formulaciones de anticuerpos anti-gen de activacion de linfocitos 3 (anti-lag3) y anticuerpos anti-muerte programada-1 (anti-pd-1).
AU2019378874B2 (en) * 2018-11-14 2025-05-29 Avm Biotechnology, Llc Stable glucocorticoid formulation
BR112021009548A2 (pt) * 2018-11-16 2021-08-17 Samsung Bioepis Co., Ltd. composição líquida estável que compreende proteína
CN109821076B (zh) * 2019-03-13 2021-05-07 陕西师范大学 一种抗凝抗感染的多功能涂层的制备方法及抗凝抗感染的多功能材料
PL3744682T3 (pl) * 2019-03-29 2022-03-07 Kortuc Inc. Ampułko-strzykawka z roztworem nadtlenku wodoru o doskonałej przedłużonej trwałości nadtlenku wodoru z wykorzystaniem oleju silikonowego (kompozycji olejowej zawierającej olej silikonowy)
US20230047299A1 (en) * 2020-01-28 2023-02-16 Zeon Corporation Pre-filled drug package and method of producing pre-filled drug package
US11739153B2 (en) 2020-09-18 2023-08-29 Chugai Seiyaku Kabushiki Kaisha Anti-HLA-DQ2.5 antibody and its use for the treatment of celiac disease
CN117120125A (zh) * 2021-03-30 2023-11-24 肖特制药瑞士股份公司 用于低温储存药物组合物的系统、液体组合物、方法和用途
WO2022207655A1 (en) * 2021-03-30 2022-10-06 Schott Schweiz Ag System for low-temperature storage of a pharmaceutical composition, liquid composition, method and uses
JP2024520584A (ja) * 2021-06-03 2024-05-24 ベクトン ディキンソン フランス 医療用注射器用低シリコーンオイルシステムの製造方法
IL311811A (en) * 2021-10-08 2024-05-01 Chugai Pharmaceutical Co Ltd Drug formulation of an anti-HLA-DQ2.5 antibody
US20240404622A1 (en) * 2021-10-08 2024-12-05 Chugai Seiyaku Kabushiki Kaisha Method for preparing prefilled syringe formulation
CN119789882A (zh) * 2022-08-30 2025-04-08 美国安进公司 限制注射器中的亚可见颗粒的系统和方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652763A (en) * 1985-03-29 1987-03-24 Energy Sciences, Inc. Electron-beam irradiation sterilization process
US6551576B1 (en) * 1989-12-22 2003-04-22 Bristol-Myers Squibb Medical Imaging, Inc. Container with multi-phase composition for use in diagnostic and therapeutic applications
US6146657A (en) * 1989-12-22 2000-11-14 Imarx Pharmaceutical Corp. Gas-filled lipid spheres for use in diagnostic and therapeutic applications
US5773024A (en) * 1989-12-22 1998-06-30 Imarx Pharmaceutical Corp. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5519984A (en) * 1995-03-16 1996-05-28 Mallinckrodt Medical, Inc. Methods for packaging a pressure or vacuum sensitive product
JP3329219B2 (ja) * 1997-02-05 2002-09-30 スズキ株式会社 船外機の電装部品設置構造
JP4460762B2 (ja) * 1997-10-15 2010-05-12 旭化成ファーマ株式会社 トロンボモジュリン水溶液注射剤の貯蔵・流通時の品質保持方法
US6274169B1 (en) * 1999-08-02 2001-08-14 Abbott Laboratories Low oxygen content compostions of 1α, 25-dihydroxycholecalciferol
EP1232753B1 (en) * 1999-09-08 2008-03-19 Chugai Seiyaku Kabushiki Kaisha Stable protein solution filled in a container made from a hydrophobic resin and method of stabilizing the same
US6595961B2 (en) * 2001-04-16 2003-07-22 Becton, Dickinson And Company Sterilizable transfer or storage device for medicaments, drugs and vaccines
NZ530765A (en) * 2001-06-26 2006-11-30 Amgen Fremont Inc Antibodies that bind OPGL and compositions and methods for the treatment of bone diseases
US20030104996A1 (en) * 2001-08-30 2003-06-05 Tiansheng Li L-methionine as a stabilizer for NESP/EPO in HSA-free formulations
SI1946776T1 (sl) * 2002-02-27 2017-07-31 Immunex Corporation Stabiliziran tnfr-fc sestavek, ki obsega arginin
KR20060015574A (ko) * 2003-05-23 2006-02-17 노보 노르디스크 헬스 케어 악티엔게젤샤프트 용액 중 단백질 안정화
JP2007521315A (ja) * 2003-08-01 2007-08-02 アムジェン インコーポレイテッド 結晶性腫瘍壊死因子レセプター２ポリペプチド

Also Published As

Publication number Publication date
WO2009099641A3 (en) 2011-02-24
CN102202643A (zh) 2011-09-28
ZA201005779B (en) 2014-12-23
ZA201109364B (en) 2015-11-25
CA2714006A1 (en) 2009-08-13
EP2249801A2 (en) 2010-11-17
SG10201402265YA (en) 2014-08-28
JP2015042638A (ja) 2015-03-05
IL207340A0 (en) 2010-12-30
EA201001223A1 (ru) 2011-06-30
US20110060290A1 (en) 2011-03-10
WO2009099641A2 (en) 2009-08-13
JP2011519347A (ja) 2011-07-07
KR20100138908A (ko) 2010-12-31
AU2009210741A1 (en) 2009-08-13
MX2010008696A (es) 2010-08-30
CN103720587A (zh) 2014-04-16

Similar Documents

Publication Publication Date Title
BRPI0908361A2 (pt) Seringas previamente cheias contendo composição e métodos de preparação das mesmas e de estabilização de agente de ligação específico em composição.
FIC20240036I1 (fi) Geeniterapia, joka ilmentää ihmisen hyytymistekijä IX:n muunnosta R338L
IL264316B1 (en) Stable liquid formulations containing anti-il-1beta antibody, syringes and self-injection syringes containing them
BRPI0819361A2 (pt) Composição de tratamento de cabelos e agente de tratamento
BRPI0920030A2 (pt) agente de oclusão do tecido
IL221372A0 (en) 6 -benzylphenyl- 2 - sulfurterahydropyran-3, 4, 5 -triol derivatives as inhibitors of sodium -glucose cotrans porters 1 and 2 for use in diabetic patients
EP2120959A4 (en) METHOD AND COMPOSITIONS FOR TREATING INSULIN RESISTANCE, DIABETES AND DIABETES-BASED DYSLIPIDEMIA
BR112013013414A2 (pt) dispositivos de coleta de sangue contendo agente de estabilização de sangue
BR112014023937A2 (pt) composição farmacêutica, agente farmacêutico de combinação e método de tratamento
EP2563426A4 (en) APPLICATION WITH HIGH SCAM FOR MEDICAL THERAPY
BRPI0811270A2 (pt) Alimento de baixo teor de gordura, e, agente de intensificação de sabor
PL2583703T3 (pl) Samoniszcząca strzykawka insulinowa z wymienną igłą
BR112015000527A2 (pt) agente reológico, métodos de preparação e usos dos mesmos.
ZA201305498B (en) Methods and compositions suitable for managing blood glucose in animals
BRPI1011188A2 (pt) composições de liberação dérmica compreendendo complexos de partículas de agente ativo-fosfato de cálcio e métodos para usar as mesmas.
BRPI0910760A2 (pt) método para remineralizar tecido, agente remineralizador, e, kit
EP2879686A4 (en) COMPOSITIONS AND METHODS FOR REDUCING THE BLOOD ALCOHOLIC STRENGTH
BRPI0821720A2 (pt) Aplicação de líquidos iônicos, magnéticos como agente de extração
HU0800434D0 (en) Template to determine the places of the injections, especially for regular medicament injection and/or blood testing
BRPI0819719A8 (pt) compostos de inibição de dipeptidil peptidase-iv, métodos de preparação dos mesmos, e preparações farmacêuticas contendo os mesmos como agente ativo
DK2407474T3 (da) Triacetyl-3-hydroxyfenyladenosin og dets anvendelse til regulering af blodfedt
BR112013015798A2 (pt) composição de agente de formação de imagem, método de preparar uma composição de agente de formação de imagem, e, composição farmacêutica
BRPI0915527A2 (pt) pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos
DK2352493T3 (da) Terapeutisk, diætetisk eller kosmetisk anvendelse af forbindelser med specifik antiapoptotisk aktivitet mod caspase-3 og sammensætninger, der indeholder disse forbindelser
IL207722A (en) Pyridopyrazinone Derivatives as Insulators, Methods of Preparation and Use for Diabetes

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: COM BASE NA RESOLUCAO 228/09, SOLICITA-SE QUE SEJAM APRESENTADOS NOVOS CD S/DVD S, POIS O ARQUIVO DE LISTAGEM DE SEQUENCIA NAO FOI APRESENTADO NO FORMATO TXT E SOLICITA-SE A APRESENTACAO DE DECLARACAO IMPRESSA E ASSINADA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2364 DE 26-04-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.